alisertib,paclitaxel
puma
['alisertib', 'biomarker', 'breast', 'paclitaxel', 'puma', '$pbyi']
puma biotechnology announces presentation of biomarker findings from a phase ii study of alisertib with paclitaxel versus paclitaxel alone in metastatic or locally recurrent breast cancer at the 2023 asco annual meeting - health stocks hub $pbyi 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2